-
公开(公告)号:US20130295590A1
公开(公告)日:2013-11-07
申请号:US13885376
申请日:2011-11-08
申请人: David Degraff , Robert Matusik , Peter Clark , Dan Theodorescu
发明人: David Degraff , Robert Matusik , Peter Clark , Dan Theodorescu
IPC分类号: G01N33/68
CPC分类号: G01N33/6893 , G01N33/57407 , G01N2333/4703 , G01N2800/52 , G01N2800/56
摘要: The present invention provides for a proteomic approach to predicting, diagnosing and staging invasive bladder cancer, and for predicting patient survival and therapeutic efficacy. More specifically, the target being analyzed for reduced expression is FOXA1, and optionally including analysis of increased FOXA2 expression.
摘要翻译: 本发明提供了用于预测,诊断和分期侵袭性膀胱癌以及用于预测患者存活和治疗功效的蛋白质组学方法。 更具体地,被分析用于降低表达的靶是FOXA1,并且可选地包括增加的FOXA2表达的分析。
-
公开(公告)号:US20060101531A1
公开(公告)日:2006-05-11
申请号:US11208257
申请日:2005-08-19
IPC分类号: A01K67/027
CPC分类号: A01K67/0275 , A01K2217/05 , A01K2227/105 , A01K2267/0331 , C12N9/6424 , C12N15/8509 , C12N2830/008 , C12N2830/15 , C12N2830/42 , C12N2830/85 , C12N2840/203
摘要: Transgenic, non-human animal model of cancer, methods of making such animals and methods of using such animals to screen test compounds are provided.
摘要翻译: 提供了转基因,非人动物癌症模型,制备动物的方法以及使用这些动物筛选测试化合物的方法。
-